Welcome to Burdica Biomed Ltd

Burdica Biomed Limited (BBL) is a fast-growing biotechnology and medical devices company. It is engaged in manufacturing and marketing of products based on the application of advanced biopolymers, and in research and development relating to biopolymer technologies. Its core area of expertise is the therapeutic application of the biopolymer hyaluronic acid (HA).

The company was established in 2007 in Scotland by Kevin Burd, an American production engineer with extensive experience of operations management in the medical devices industry. The company has now built a strong, widely experienced and highly motivated team which is driving its continuing development.

Less than two years after its establishment, Burdica launched its first product, Zestica Fertility™, a personal lubricant using the fertility enhancing properties of HA. The product range was subsequently augmented by the introduction of Zestica Moisture™, designed to alleviate the dryness and discomfort which is experienced by many women during and after the menopause, and in some cases by younger women as a result of certain medical conditions. Other complementary products are under development.

BBL is engaged in a programme of research and development expected to yield significant future enhancements and refinements of HA technology, and to lead to future generations of HA-based products.